Testing Oversight Debate
Michael discusses the inconsistencies in testing regulations, highlighting the lack of oversight for pooled testing while rapid tests face stringent FDA requirements. He questions the logic behind designating tests that alter individual behavior as medical devices, pointing out the greater risk posed by pooled tests that can affect multiple people at once. The conversation delves into the complexities of public health tools and the implications for effective COVID-19 testing strategies.In this clip
From this podcast
Lex Fridman Podcast
Michael Mina: Rapid COVID Testing | Lex Fridman Podcast #235
Related Questions
What went wrong with the response to the COVID-19 pandemic as discussed in the episode Michael Mina: Rapid COVID Testing | Lex Fridman Podcast #235 and the clip Testing and Accountability?
How does the FDA regulate drugs and medical devices as discussed in the episode Michael Mina: Rapid COVID Testing | Lex Fridman Podcast #235 and the clip FDA and Rapid Testing?